DeepIntent

What DeepIntent does

DeepIntent is a healthcare-specialized demand-side platform (DSP) founded in 2016 and headquartered in New York City, with an engineering office in Pune, India. The company unifies media, identity, and clinical data through its proprietary Health Intelligence technology to enable pharmaceutical brands and their agencies to plan, activate, and optimize programmatic advertising campaigns across omnichannel touchpoints including CTV, display, native, audio, DOOH, video, and EHR environments. Its data footprint spans 3.7 million+ verified healthcare professionals (covering 98% of the US prescribing HCP universe) and 250 million+ patient profiles, refreshed daily via claims data. The platform powers 600+ pharmaceutical brands and is used by all leading healthcare agencies, including Merck, AstraZeneca, Pfizer, Gilead, Teva, and Amgen on the brand side and Publicis Health Media, Deerfield Group, and Good Apple on the agency side.

The product architecture combines the core DeepIntent DSP with the Cortex optimization layer and the newly launched Helix healthcare marketing cloud (March 2026) and Helix AI agentic AI layer (June 2026). Helix AI enables natural language querying of healthcare data, audience building, and cross-platform campaign activation, reportedly cutting planning cycle time by 50% in beta testing. The company holds three patents, maintains HIPAA and NAI compliance, and operates certification programs (DSP, Cortex Essentials, Digital Health Marketing/Targeting) to deepen client embedment. Recent strategic integrations with OptimizeRx, epocrates, and Lane4.io extend programmatic reach into authenticated EHR and point-of-care inventory, areas previously inaccessible to generalist DSPs.

DeepIntent monetizes primarily through DSP fees on programmatic media buying, supplemented by data and audience services (premium health data segments and measurement) and managed services. Pricing is enterprise-oriented, quote-based, and structured around multi-year contracts, with both self-service platform access and full-service managed campaign execution available. In September 2025, the company secured a $637 million private equity investment from Vitruvian Partners, the largest funding in its history, intended to accelerate its AI-driven transformation of healthcare marketing.

Name

DeepIntent

Legal name

DeepIntent, Inc.

Website

https://deepintent.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

251–500 employees

Short description

DeepIntent is a healthcare-specialized demand-side platform that enables pharmaceutical brands and agencies to plan, activate, and optimize programmatic advertising across CTV, display, audio, video, and EHR channels, reaching 98% of US prescribing HCPs and 250M+ patient profiles.

Ownership category

akta.pro rank

Product category

Healthcare Advertising Demand-Side Platform (DSP)

NAICS

Media Buying Agencies (541830), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518)

SIC

Services-Health Services (8000), Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

Healthcare/Pharma Creative Agencies (MPAAAAAJ)

Keywords

• Healthcare advertising platform
• Pharmaceutical programmatic advertising
• Demand-side platform DSP
• HCP audience targeting
• Healthcare marketing technology

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations

Revenue model

1. Demand-Side Platform (DSP) Fees: DeepIntent operates as a healthcare-specific demand-side platform, charging fees for programmatic media buying and advertising technology services to pharmaceutical brands and agencies.
2. Data and Audience Services: Revenue generated from providing premium health data segments, advanced targeting capabilities, and measurement products to healthcare marketers.
3. Managed Services: Expert campaign assistance including planning, activation, and optimization services for clients requiring hands-on support.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

DeepIntent operates a healthcare-specific demand-side platform (DSP) that enables pharmaceutical brands and agencies to plan, activate, and optimize programmatic advertising campaigns across audio, CTV, display/native, DOOH, EHR, and video channels. The platform unifies media, identity, and clinical data through its proprietary Health Intelligence™ technology, allowing precision targeting of 3.7M+ verified healthcare professionals and 250M+ patient profiles in a HIPAA- and NAI-compliant environment. It sells directly to enterprise pharma companies and healthcare agencies, supplemented by managed services and data/audience offerings.

Product overview

DeepIntent is a healthcare advertising demand-side platform (DSP) offering a unified platform-plus-modules architecture. The core DeepIntent platform enables programmatic media buying across healthcare channels (CTV, display, video, audio, DOOH, EHR) powered by patented health intelligence technology. Key modules include: Helix™ (healthcare marketing cloud launched March 2026) and Helix AI (agentic AI layer launched June 2026 enabling natural language querying of 4M+ HCPs and 250M+ patient profiles); DeepIntent Cortex™ (intelligence layer for optimization and audience quality); and HealthFirst™ Media Suite (premium inventory packages). The platform is HIPAA and NAI-compliant and reaches 98% of the prescribing HCP universe with 3.7M+ verified HCPs and 250M+ patient profiles.

Differentiator

Problem solved

Functional benefit

Brands

• Helix: Purpose-built healthcare marketing cloud platform that enables marketers to explore healthcare data, build audiences, and activate campaigns using natural language.
• Helix AI
• Cortex
• HealthFirst

Products and services

• DeepIntent Platform Healthcare advertising demand-side platform (DSP) that unites media, identity, and clinical data to enable programmatic ad buying across healthcare channels including CTV, display, video, audio, DOOH, and EHR. Powers campaigns for pharmaceutical brands with real-time optimization and reaches 98% of prescribing HCPs.
• Helix™ Healthcare Marketing Cloud Purpose-built healthcare marketing cloud providing integrated audience building, campaign activation, and commercial insights capabilities for healthcare marketers on top of DeepIntent's DSP.
• Helix AI Agentic AI platform purpose-built for healthcare marketers enabling natural language querying of healthcare databases covering 4M+ HCPs and 250M+ patient lives, audience building, and cross-platform campaign activation. Reduces planning cycle time by 50%.
• DeepIntent Cortex™ AI-powered health intelligence optimization and decisioning technology combining clinical and media data for smarter media buying, real-time optimization, and scalable campaign performance across healthcare KPIs.
• HCP Solutions Healthcare professional engagement solution enabling precision targeting and scale to verified HCPs (3.7M+) for meaningful pharma campaign impact across omnichannel programmatic inventory.
• DTC Solutions Direct-to-consumer campaign solutions using data-driven targeting to connect pharmaceutical brands with 250M+ patient profiles at the right moment for effective patient campaigns.
• Integrated Solutions Unified approach bridging HCP and DTC engagement to maximize reach and amplify outcomes across the patient care journey with cross-channel optimization.
• Custom Solutions (Managed Services) Managed services providing expert campaign assistance including planning, activation, and optimization support delivered by DeepIntent specialists for clients requiring hands-on support.
• HealthFirst™ Media Suite Media package solution offering premium inventory and audio packages for connecting healthcare brands to trusted streaming publishers, including HealthFirst Vaccine Audiences recognized as an innovation by PM360 in 2024.
• FAST Solution Free Ad-Supported TV solution connecting healthcare brands to premium streaming supply at scale.

Quantifiable outcome

• 50% improvement in planning cycle time for agency users
• +3 more outcomes

Named customers9 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability4 records

Feature7 records

Partnerships

Seven partnerships are on record, tiered core.

• Lane4.iocoreTechnology or Integration · 28 May 2026Partnership to launch a new programmatic path to point-of-care inventory. Lane4.io is a supply-side platform built specifically for Electronic Health Record (EHR) and health media advertising. The partnership aims to expand programmatic access to point-of-care media with new features launching mid-June 2026.
• epocratescoreTechnology or Integration · 26 May 2026First-to-market partnership making epocrates' clinical inventory programmatically available within the epocrates clinician workflow. The integration enables advertisers to reach verified healthcare professionals at the point of care using real-time contextual signals, including drug lookups and clinical activity, within a logged-in, brand-safe environment.
• OptimizeRxcoreTechnology or Integration · 21 May 2026DeepIntent became the first DSP to integrate OptimizeRx's proprietary authenticated electronic health record (EHR) network into its advertising platform. The integration enables life sciences marketers to activate advertising within healthcare provider workflows at clinically relevant decision moments using a privacy-safe solution. Expected to be available in Q3 2026.
• MAGNA (IPG Mediabrands)coreStrategic or Co-development Partner · 10 October 2024Research partnership conducting the 'Beyond the Prescription' study exploring the impact of pharmaceutical advertising on patient behavior, health management, and outcomes. The proprietary research surveyed over 1,100 patients and 1,000 doctors to uncover how pharma ads influence patient health outcomes beyond traditional promotional roles.
• Everyday Health GroupcoreStrategic or Co-development Partner · 10 September 2024Strategic partnership providing agencies and brands priority access to Everyday Health Group's premium health-focused platform with trusted and reviewed health content. Includes first-look access to EHG's premium inventory across properties including Everyday Health, BabyCenter, WhatToExpect, MedPage Today, and EHG's Trusted Care Access Portfolio (TCAP) of leading medical center sites.
• Publicis Health MediacoreGTM or Marketing PartnerAgency partnership where Publicis Health Media utilizes DeepIntent's platform for healthcare advertising campaigns. Publicis CEO Andrea Palmer noted that the partnership has simplified go-to-market strategy for clients' campaigns by enhancing speed and access to unique data and inventory.
• Deerfield GroupcoreGTM or Marketing PartnerStrategic partnership combining DeepIntent's platform with Deerfield Group's healthcare marketing and media expertise to deliver meaningful impact. The partnership leverages high-quality data, premium inventory access, and commitment to innovation to craft strategies that accelerate brand growth.

Scale indicators7 records

Recent moves6 records

Expansion highlights7 records

Direct peers

• Pulsepoint: Pulsepoint operates a programmatic ad-tech platform with significant healthcare vertical focus, competing directly with DeepIntent for pharma brand and agency budgets in omnichannel programmatic buying. Both companies serve the HCP and DTC healthcare advertising market with comparable DSP capabilities.
• Swoop (IQVIA): Swoop, now part of IQVIA, provides healthcare-specific audience targeting, identity resolution, and programmatic activation—directly competing with DeepIntent's Health Intelligence capabilities. Both companies leverage health data assets to enable pharma marketers to reach HCPs and patients with privacy-safe precision.
• Crossix (Veeva Systems): Crossix, now part of Veeva, offers healthcare marketing analytics and audience solutions for pharma brands, competing with DeepIntent's measurement and targeting capabilities. Both serve pharma marketers with clinical data integration and campaign analytics for measuring script lift and audience quality.

Emerging players

• PatientPoint: PatientPoint is a point-of-care health media company reaching patients and HCPs in physician offices, partially overlapping with DeepIntent's recent EHR/point-of-care expansion. Their owned inventory represents a complementary or competitive channel for pharma advertisers depending on integration terms.
• Outcome Health: Outcome Health provides point-of-care health media and HCP engagement solutions across digital channels in clinical settings. Their EHR-integrated advertising platform overlaps with DeepIntent's emerging point-of-care inventory partnerships, particularly for reaching verified HCPs at clinical decision moments.

Broad incumbents

• The Trade Desk: The Trade Desk is the largest independent DSP globally, with growing healthcare vertical investment that directly competes with DeepIntent for pharma programmatic budgets. While not healthcare-specific, its scale, data partnerships, and recent recruitment of DeepIntent's prior CMO position it as a major competitive threat.
• WebMD (Internet Brands): WebMD operates one of the largest health information and DTC advertising platforms, serving both endemic pharma advertising and broader health audiences. Its massive consumer health audience represents both a potential inventory partner and a competing advertising destination for pharma brands.

Others

• LiveRamp: LiveRamp provides identity resolution and data collaboration infrastructure that underpins much of the programmatic ecosystem, including healthcare advertising. While not a direct competitor, DeepIntent depends on similar data infrastructure for its targeting capabilities, making LiveRamp both an enabler and potential disintermediator.
• Definitive Healthcare: Definitive Healthcare provides healthcare commercial intelligence and data analytics used by pharma marketers for HCP targeting and market intelligence. While primarily a data/analytics provider rather than an ad-tech platform, its healthcare data assets overlap with DeepIntent's HCP targeting capabilities.
• Magnite: Magnite is the largest independent sell-side platform (SSP) for CTV and video advertising, supplying inventory that DeepIntent's DSP activates for pharma marketers. As a critical infrastructure provider in the programmatic ecosystem, Magnite's pricing and policies directly impact DeepIntent's unit economics on CTV campaigns.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/10609864
• Xx.com/DeepIntent_
• Facebookfacebook.com/deepintentinc

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles18 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DeepIntent